Updated Monday through Friday
- Drug Firm Annual Registration Status
- Drug Firm Annual Registration Status Download File
- National Drug Code Directory
- NDC Unfinished Drugs Excluded Database File
- NDC Database Excluded Packages and Products
- Wholesale Distributor and Third-Party Logistics Providers Reporting
August 26, 2020
- Manual of Policies and Procedures (MAPP) 5242.1 Transfer of Ownership
- FDA Drug Safety Communication: FDA removes Boxed Warning about risk of leg and foot amputations for the diabetes medicine canagliflozin (Invokana, Invokamet, Invokamet XR)
- CDER Statement: FDA works to mitigate shortages of rifampin and rifapentine after manufacturers find nitrosamine impurities
.png)
No hay comentarios:
Publicar un comentario